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Neonatal sepsis is a disease affecting newborns £ 1month of agewith clinical symptoms and positive blood cultures.
The number of Escherichia coli strains causing neonatal sepsis resistant to the antibiotics used in the treatment is
increasing. In this study, two E. coli strains causing sepsis in neonates of mothers infected with an E. coli strain
harboring extended spectrum beta-lactamases were characterized. The blaCTX-M-15 and the blaCTX-M-14 genes were
found in an IncFIA and nontypeable transferable plasmids, respectively. In addition, these highly virulent strains
belonged to ST705 and ST156 clonal groups, respectively. The presence of strains, which are highly virulent and
resistant to ampicillin, gentamicin, and cephalosporins,makes a change in empirical treatment necessary aswell as an
increase in the surveillance of these infections.
Introduction
Bacterial infection is an important cause of morbidityand mortality in neonates despite the great improve-
ments in intensive neonatal care and the use of extended
spectrum antimicrobial agents. Neonatal sepsis is a disease
affecting newborns £ 1 month of age with clinical symp-
toms and positive blood cultures. Neonatal sepsis can be
subdivided into early-onset neonatal sepsis (EONS) that is
caused by microorganisms acquired from the mother before
or during birth and late-onset neonatal sepsis (LONS) when
the infection is presented 4 days or more after birth, due
mainly to the microorganisms of the environment.
Group B Streptococcus is considered to be the most
common microorganism causing EONS, but there have been
reports of an increase in the incidence of EONS by Es-
cherichia coli, especially in premature or very low birth weight
neonates.3,26,27
Newborns presenting sepsis are treated with ampicillin,
gentamicin, or cephalosporins. However, the number of
E. coli strains causing neonatal sepsis resistant to these
antibiotics is increasing.3,12,19,29 The emergence of extended
spectrum beta-lactamases (ESBL)-producing E. coli in ne-
onates1,12,13,23,24 makes epidemiological surveillance for
vertical transmission of neonatal sepsis necessary, being of
special interest in the cases of newborns from mothers with
obstetric risk factors.
The aim of this study was to characterize E. coli strains
harboring ESBL causing neonatal sepsis.
Materials and Methods
Bacteria
Two E. coli strains causing EONS (Ec-EONS) and LONS
(Ec-LONS) collected in 2008 from neonates whose mothers
presented an intra-amniotic infection also caused by an
E. coli ESBL producer were studied.
Antimicrobial susceptibility
Minimal inhibitory concentrations (MICs) were deter-
mined using the MicroScan-Negative MIC Panel Type 37
(NM37; Siemens). Results were interpreted following the
CSLI guidelines.9 The E. coli ATCC25922 strain was used
as control.
Detection of resistance genes
We detected the following selected antimicrobial
resistance genes: blaTEM1-like and blaOXA1-like in all ampi-
cillin-resistant strains; tetA, tetB, tetC, tetD, and tetG in
tetracycline-resistant strains; dfrA, dfrIb, and dfrVII in tri-
methroprim-resistant strains; sul1, sul2, and sul3 in sulfa-
diazine (Sd)-resistant strains; aac(3)-IV and aac(3)-II in
gentamicin-resistant strains; and catA, cmlA, and floR in
choramphenicol-resistant strains. Mutations in the quinolone
resistance-determining region (QRDR) of the genes encod-
ing the essential enzymes, DNA gyrase and topoisomerase
IV, were determined by polymerase chain reaction (PCR)
and sequencing.10 The blaCTX-M genes and their link with
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the ISEcp1 insertion sequence were analyzed by PCR using
specific primers and sequencing of the resulting frag-
ments.5,11 The sequences obtained were compared with
those registered in GenBank.
Gene location
Plasmid DNA was extracted from the E. coli isolates
using the Kado and Liu and S1 method,15 transferred onto
membranes, and hybridized with probes for blaCTX-M genes
as described.10 Conjugation experiments were performed as
reported,10 using the kanamycin-resistant strain E. coli K7
759Lac- as recipient. The incompatibility group of the
plasmids was determined using the PCR-based inc/rep typ-
ing method described by Carattoli et al.6
Epidemiological characterization
The phylogenetic group of the isolates was analyzed by
a triplex-PCR.8 MLST was analyzed by amplification of
seven housekeeping genes (adk, fumC, icd, purA, gyrB,
recA, and mdh) (www.web.mpiib-berlin.mpg.de/mlst).
Virulence profiles were analyzed by PCR using gene-
specific primers for 17 virulence genes.25 The PCR condi-
tions used have been described elsewhere.14
Results
The two cases presented in this study were independent
episodes that happened over 10 years in our hospital, from
1998 to 2008. No outbreaks by E. coli harboring ESBLs
were reported in the period under study. The Ec-EONS
strain was collected from a newborn within the first 24 hr of
life, and the Ec-LONS strain was isolated from a child 4
days after birth.
The Ec-EONS strain presented the blaCTX-M-15 gene and
the Ec-LONS strain presented the blaCTX-M-14 gene. The
blaCTX-M gene was linked with the ISEcp1 insertion
sequence in both cases. In addition to cephalosporin resis-
tance, the Ec-EONS strain showed resistance to cipro-
floxacin due to a mutation in the QRDR region of the gyrA
gene (Asp87 to Lys) and two mutations in the QRDR region
of the parC gene (Ser80 to Ile and Glu84 to Val), and gen-
tamicin due to the presence of the aac(3)-II. The Ec-LONS
strain presented resistance to chloramphenicol caused by the
presence of the cml1 gene, ciprofloxacin due to a mutation
in the QRDR region of the gyrA gene (Ser83 to Leu), tet-
racycline by the presence of the tetA gene, and trime-
throprim-sulfamethoxazole encoded by the dfrA12 and sul2
genes, respectively.
Ec-EONS presented two transferable plasmids of about
400- and 145-kb. The Ec-LONS presented three plasmids of
about 95-, 120-, and 205-kb (Fig. 1a, b), but only the plas-
mid of about 120-kb was present in the transconjugant
isolates. Hybridization experiments demonstrated the pres-
ence of the blaCTX-M-14 gene in the nontypeable plasmid of
120-kb (Fig. 1c), whereas the blaCTX-M-15 gene was found in
the plasmids of 145-kb belonging to the IncFIA incompat-
ibility group (Fig. 1d).
FIG. 1. Plasmid analysis of the Escherichia coli strains under study. (a) Plasmid profile obtained by the Kado-Liu
protocol. (b) Plasmid profile obtained by S1 protocol. (c) Hybridization with the blaCTX-M-14 gene probe. (d) Hybridization
with the blaCTX-M-15 gene probe. M in a, Lambda-DNA digested with PstI. M in b, Lambda ladder PFGE marker (New
England Biolabs). K, kanamycin-resistant strain E. coli strain K12 J53 used as recipient. P, Ec-EONS wild-type strain; Pa to
Pc, transconjugants obtained from Ec-EONS. T, Ec-LONS wild-type strain; Ta, transconjugant obtained from Ec-LONS.
Ec-EONS, E. coli strains causing early-onset neonatal sepsis; Ec-LONS, E. coli strains causing late-onset neonatal sepsis.
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A further characterization of the strains was carried out.
The Ec-EONS strain belonged to the virulent phylogenetic
group B2, ST705, and presented 14 virulence factors. On the
other hand, the Ec-LONS was less virulent and belonged to
the phylogenetic group D, ST156, and presented 10 viru-
lence factors (Table 1).
Discussion
The increase of antimicrobial resistance among E. coli
strains causing neonatal sepsis is becoming an important
problem.12 The percentage of strains resistant to ampicillin
and gentamicin is on the rise, cephalosporins being the al-
ternative treatment in these cases. However, the number of
strains resistant to cephalosporins is also becoming an in-
creasingly notable problem in developing countries.1,21,24
Several studies on the presence of ESBLs among neo-
nates or in neonatal intensive care units (NICUs) in India
have been reported, but only reporting percentages of
ESBL-producing E. coli.1,13,23 The percentages of neonatal
sepsis caused by ESBL-producing E. coli were found to be
between 52–65.3%.1,7,13,23 Shakil et al.,23 found blaCTX-M-15
in five preterm neonates from NICU. All of these E. coli
strains presented transferable plasmids. E. coli belonging to
ST131 and harboring blaCTX-M-15 was also associated with
cases of neonatal meningitis.22 In contrast, the strain studied
in the present study belonged to ST705.
In developed countries, only a few cases of ESBL-
producing E. coli have been reported in NICUs.17,28 Boyer-
Mariotte et al.4 reported a case of fatal meningitis and sepsis
in a newborn caused by an E. coli strain belonging to the
phylogenetic group B2 and harboring blaCTX-M-15. In con-
trast to our findings, in which the strains presented more
than 10 virulence factors, this strain only presented aero-
bactin and yersiniabactin as virulence factors.
The CTX-M-14 enzyme has been reported worldwide, but
has been substituted by CTX-M-15 in the last years.2 An
outbreak caused by a strain of E. coli presenting the CTX-
M-14 enzyme has been reported in the literature.20 The
blaCTX-M-14 gene was found in an IncK plasmid of about 80-
kb. This strain belonged to ST23 and phylogenetic group A.
In addition, the blaCTX-M-14 gene was linked to an ISEcp1
insertion sequence. The strain characterized in the present
study also presented the blaCTX-M-14 gene, but was different
to that described in the previously commented study in both
clonal and phylogenetic groups. Other E. coli strains be-
longed to ST156, but carrying different ESBL genes were
found in China and United Kingdom.18,21
The presence of antimicrobial-resistant strains in neonates
makes it necessary to avoid empirical treatment in these
cases. Lo´pez-Cerero et al.16 studied the case of a neonate
whose mother presented premature membrane rupture and
fever and was treated with ampicillin and gentamicin. The
neonate was also treated with these two antimicrobial agents
and his condition deteriorated due to the sepsis caused by a
CTX-M-32-positive E. coli strain.
In summary, this is the first time that a CTX-M-14 pro-
ducing E. coli strain belonging to ST156 and phylogenetic
group D causing neonatal sepsis has been studied. The
presence of strains that are highly virulent and resistant to
ampicillin, gentamicin, and cephalosporins makes a change
in empirical treatment necessary as well as an increase in the
surveillance of these infections.
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